The 14th World ADC London 2024 returns this March as a crucial touchpoint for over 600 antibody drug conjugate developers across Europe.
This meeting is the place where innovation meets collaboration to drive antibody-drug conjugates forward and transform cancer therapy as we know it.
Take a look at the full agenda here.
Embark on a knowledge-rich adventure as we explore the intricate nuances of ADC development. From the initial stages of target identification and antibody engineering to the complexities of clinical trials and CMC strategies to navigating commercialisation, expect to leave this event with a comprehensive understanding of the entire ADC lifecycle.
Whether you are pioneering ADC discoveries, accelerating your conjugate through preclinical and clinical development, or optimising your CMC efforts, this is your chance to ahead of the curve with the high-quality and invaluable guidance of the supportive ADC community.
Book your ticket here with MabDesign’s exclusive code MAB15 and get 15% off your ticket.
